Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Bionorica SE expands presence in Austria

(c) Bionorica © Bionorica

Herbal medicinal products as a future growth opportunity

In addition, Austria offers an optimal environment from a phytomedical perspective, according to CEO and Bionorica owner Michael A. Popp. In 2005, Bionorica founded Bionorica Research GmbH in Innsbruck, a fully owned subsidiary. Since 2012, the phytomedicine producer is the exclusive partner of the Austrian Drug Screening Institute (ADSI). It is the world’s first research institute in which the scientific and business communities targetedly search for medically effective substances in nature.

“A great deal of know-how is required in order to derive highly effective medical agents from plants. Austria boasts a long tradition in phytomedicine, and carries out research at the highest level in this sector. In recent years, it has emerged as a ‘Silicon Valley’ of phytomedicine“, he explained.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts